HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates FIXX, TILE Investors, Encourages Investors with Losses to Contact Its Attorneys, Securities Fraud Investigations Ongoing
October 26, 2020 17:37 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the...
FIXX SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Losses to Contact Its Attorneys, Firm Investigating Possible Securities Fraud
October 14, 2020 17:28 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors with significant losses to submit your losses now. The firm is investigating...